NDC 70771-1685

Nelarabine

Nelarabine

Nelarabine is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Nelarabine.

Product ID70771-1685_3fdea8e8-07e5-41bc-964d-34b7a82e24f1
NDC70771-1685
Product TypeHuman Prescription Drug
Proprietary NameNelarabine
Generic NameNelarabine
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-11-17
Marketing CategoryANDA /
Application NumberANDA215037
Labeler NameCadila Healthcare Limited
Substance NameNELARABINE
Active Ingredient Strength5 mg/mL
Pharm ClassesNucleoside Metabolic Inhibitor [EPC],Nucleic Acid Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70771-1685-1

1 VIAL in 1 CARTON (70771-1685-1) > 50 mL in 1 VIAL
Marketing Start Date2021-11-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Nelarabine" or generic name "Nelarabine"

NDCBrand NameGeneric Name
70710-1726NelarabineNelarabine
70771-1685NelarabineNelarabine
0078-0683Arranonnelarabine

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.